Cialis, or tadalafil, is celebrated for its extended performance duration, providing effectiveness for up to 36 hours and allowing users to choose the ideal timing. Initially developed in the early 1990s, tadalafil's approval in 2003 marked a milestone for ED treatments, offering a unique advantage over shorter-acting medications. Its effect is achieved by inhibiting the PDE5 enzyme, which regulates blood flow during sexual stimulation, making tadalafil both versatile and dependable. Daily-use and as-needed options further enhance its appeal, meeting varied needs and preferences.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about CIALIFEI 5 by Keifei Pharma, consult with your doctor or healthcare professional.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.
Home
